Chengdu Kanghong News and Activities

Chengdu Kanghong is one of the...

• CSI 500;
• TOB Iconic 10,000.

Chengdu Kanghong is a company listed under the stock ticker 002773 (CN).

View the org chart displaying its 3 main executives

Most searched biographies at Chengdu Kanghong

• Xiao Ke, President and Director
• Zun Hong Ke, Chairman of the Board
• Jian Jun Zhong, Chief Financial Officer

Create your alert
to follow the executive moves at Chengdu Kanghong.

Chengdu Kanghong has 1,913 competitors including Sanofi (France), Eli Lilly (United States (USA)) and Moderna (United States (USA)).

Popular M&A news in Pharmaceuticals

• Laboratoire Servier has announced the acquisition of Edgewise Therapeutics  (posted on June 4 2026).
• Contraline has just announced a $93 Million fundraising (posted on June 3 2026).
• Hims & Hers has acquired Eucalyptus (posted on June 2 2026).

Popular contacts in Pharmaceuticals

• Joaquin Duato - Chief Executive Officer and Chairman of the Board at Johnson & Johnson
• Robert Ford - Chief Executive Officer and Chairman of the Board at Abbott
• Jonathan Leff - Director at Larimar Therapeutics

Learn more about the Pharmaceuticals industry

Press releases by Chengdu Kanghong

Social media about Chengdu Kanghong

• Chengdu Kanghong on Wikipedia, Google News & Yahoo Finance
• Chengdu Kanghong on LinkedIn, X (Twitter) & YouTube